title: Systolic hypertension; diabetes mellitus; renal dysfunction; and the use of ACE inhibitors in African-American population.
authors.forename: J D
authors.initials: JD
authors.lastname: Wurtzbacher
authors.forename: G A
authors.initials: GA
authors.lastname: Gourley
authors.forename: W C
authors.initials: WC
authors.lastname: Cushman
authors.forename: D
authors.initials: D
authors.lastname: Fine
authors.forename: J
authors.initials: J
authors.lastname: Miller
authors.forename: R
authors.initials: R
authors.lastname: Shane
authors.forename: K
authors.initials: K
authors.lastname: Schultz
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D044383:Black People; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003928:Diabetic Nephropathies / Q000150:complications*; D003955:Diagnostic Tests, Routine; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008487:Medical History Taking; D010808:Physical Examination; D001741:Black or African American
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents